Effect of octreotide, a somatostatin analogue, on release of inflammatory mediators from isolated guinea pig bladder

The Journal of Urology
D E BjorlingR Saban

Abstract

Somatostatin has been demonstrated to inhibit inflammation under certain circumstances. We hypothesized that in vivo treatment with octreotide, a long-acting analogue of somatostatin analogue, would diminish the capacity of inflammatory peptides to stimulate in vitro release of inflammatory mediators by the bladder. Female guinea pigs were injected with octreotide (20 mg./kg. i.m.) prior to euthanasia. Control guinea pigs received no treatment prior to euthanasia. Urinary bladders were removed and incubated with substance P (SP, 10 microM), neurokinin A (NKA, 10 microM), or bradykinin (BK, 10 microM) in the presence or absence of indomethacin (50 microM), and release of histamine, prostaglandins (PGE2 and PGF2 alpha), and leukotriene (LTB4) was determined. Sensory peptides and BK induced time-dependent release of histamine and eicosanoids from isolated urinary bladder. Blockade of cyclooxygenase with indomethacin (50 microM) abolished peptide-induced prostaglandin release but enhanced LTB4 release. In vivo octreotide pretreatment decreased peptide-induced histamine release, had no effect on PGE2 or PGF2 alpha release, and LTB4 release. However, octreotide prevented the increase in LTB4 release in tissues incubated with indometh...Continue Reading

References

Dec 1, 1992·The Journal of Clinical Investigation·L J CroffordR L Wilder
Nov 1, 1992·Pharmacology & Therapeutics·J M Hall
Feb 1, 1992·The British Journal of Dermatology·J Wallengren, R Håkanson
Mar 1, 1991·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·T C HuntS T Holgate
Nov 30, 1991·BMJ : British Medical Journal·M Ahmed, O W Davison
Oct 6, 1987·European Journal of Pharmacology·B J UndemG K Adams
Sep 1, 1988·British Journal of Pharmacology·M A LowmanM K Church
Jan 1, 1987·Annals of the New York Academy of Sciences·M PawlikowskiA V Schally
Jul 17, 1981·European Journal of Pharmacology·T C Theoharides, W W Douglas
Oct 1, 1984·Urology·J GuJ M Polak
Oct 1, 1980·The Journal of Urology·A FarkasI Binderman
Mar 1, 1994·Digestive Diseases and Sciences·F KarmeliD Rachmilewitz
May 1, 1994·The Journal of Clinical Investigation·K KaralisG Tolis
Apr 1, 1995·International Archives of Allergy and Immunology·V PatellaG Marone
Jun 1, 1995·British Journal of Urology·X PangT C Theoharides
Apr 1, 1995·Journal of Applied Physiology·C M LillyJ M Drazen
Jul 1, 1995·Mutation Research·J Ashby
Jun 1, 1995·Prostaglandins, Leukotrienes, and Essential Fatty Acids·M Lamacka, J Sajbidor
Jan 1, 1993·Gastroenterology·C M HogaboamJ L Wallace
Feb 1, 1994·European Journal of Clinical Investigation·P M van HagenS W Lamberts
Aug 1, 1994·Naunyn-Schmiedeberg's Archives of Pharmacology·E LachJ P Gies
Oct 1, 1994·The Journal of Urology·D E BjorlingR Saban
Apr 1, 1993·Naunyn-Schmiedeberg's Archives of Pharmacology·C A MaggiS Guliani
Jan 1, 1994·Mediators of Inflammation·D E BjorlingR Saban

❮ Previous
Next ❯

Citations

Feb 19, 2008·Der Schmerz·G Segond von Banchet
May 29, 2002·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Omar M E Abdel Salam
Mar 11, 2000·American Journal of Physiology. Renal Physiology·T G HammondM L Zeidel

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basophils

Basophils are myeloid cells with a high affinity IgE receptor and is involved in inflammatory responses during allergy. Discover the latest research on Basophils here.

Bladder Carcinoma In Situ

Bladder Carcinoma In Situ is a superficial bladder cancer that occurs on the surface layer of the bladder. Discover the latest research on this precancerous condition in this feed.